stella
beta
Immunotherapy With Dinutuximab Beta in Combination With Chemotherapy for the Treatment of Patients With Primary Neuroblastoma Refractory to Standard Therapy and With Relapsed or Progressive Disease — Stella
Home
/
High-Risk Neuroblastoma
/
View on ClinicalTrials.gov
Recruiting
Back to High-Risk Neuroblastoma trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
Poland
University Children Hospital, Krakow, Malopolska